TransCode Therapeutics Inc (NASDAQ:RNAZ) price on Wednesday, April 30, fall -5.88% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.41.
A look at the stock’s price movement, the close in the last trading session was $0.43, moving within a range at $0.3866 and $0.425. The beta value (5-Year monthly) was 1.519. Turning to its 52-week performance, $66.33 and $0.22 were the 52-week high and 52-week low respectively. Overall, RNAZ moved -17.86% over the past month.
TransCode Therapeutics Inc’s market cap currently stands at around $9.49 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RNAZ is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
RNAZ’s current price about 3.35% and -73.34% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.65, while 7-day volatility ratio is 22.99% and 21.29% in the 30-day chart. Further, TransCode Therapeutics Inc (RNAZ) has a beta value of 1.52, and an average true range (ATR) of 0.18.
If we refocus on TransCode Therapeutics Inc (NASDAQ:RNAZ), historical trading data shows that trading volumes averaged 4.94 over the past 10 days and 7.14 million over the past 3 months. The company’s latest data on shares outstanding shows there are 23.34 million shares.
The 10.11% of TransCode Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 0.78% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.04 million on 2025-04-15, giving us a short ratio of 0.07. The data shows that as of 2025-04-15 short interest in TransCode Therapeutics Inc (RNAZ) stood at 444.99997 of shares outstanding, with shares short rising to 0.34 million registered in 2025-03-14. Current price change has pushed the stock -87.93% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RNAZ stock continues to rise going into the next quarter.
